alfimeprase (Niche Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namealfimeprase (Niche Therapeutics)
Drug Alias Namealfimeprase
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionFibrinolysis stimulants
TargetsUpdating
Therapy Area/IndicationsCoronary Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNiche Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNiche Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsCoronary Thrombosis

Other Information

ATC CodeN/A
Related LinksN/A